Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Institut Catala de Retina
Age
50–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Patients with chronic, primary or secondary, open or closed angle glaucoma, diagnosed by meeting the following criteria:
* Signs of structural damage: thinning of the optical nerve or peripapillary hemorrhage or decrease in the nerve fiber layer that can be seen by OCT.
* Signs of functional damage: 3 points outside 95% of the normal limit on the visual field pattern deviation graph.
2. There must be at least 3 reliable visual fields prior to the start of the study.
3. Patients between 50 and 75 years old, homogeneously distributed among the groups.
4. Glaucoma with functional and structural damage.
* Medium grade, Mean Deviation (MD) between -4 and -20 dB.
* In at least one eye.
You may not be if
1. Treatment with some other vitamin or nutraceutical preparation.
2. Any pathology that can alter the visual field. (Neurological diseases, retinopathies, advanced cataract, patients treated with lyrica (due to the affectation it produces in the visual field)).
3. Hypersensitivity to aspirin. (Cross-allergic reaction has been reported in patients taking citicoline.)
4. Allergic to fish protein.
5. Eye surgery in the 3 months before or during the study.
